Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | BMC Genomics

Fig. 1

From: The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence

Fig. 1

Single Nucleotide Polymorphisms (SNP) in each of the Muguga Cocktail component T. parva stocks relative to the reference T. parva Muguga isolate. a) Number of base pairs in the reference T. parva Muguga genome assembly with no read coverage from each of the three isolates. SNPs cannot be identified in this fraction of the genome, respectively 0.55 % (45,837 bp), 0.29 % (24,439 bp) and 5.61 % (466,092 bp) of the genome, in the comparisons with Muguga clone 2, Serengeti-transformed and Kiambu5. b) Identified SNPs unique to, and shared among, Muguga clone 2, Kiambu5, and Serengeti-transformed isolates

Back to article page